160 related articles for article (PubMed ID: 22483466)
1. Serum adiponectin levels in renal transplant recipients with and without metabolic syndrome.
Shu KH; Tsai IC; Ho HC; Wu MJ; Chen CH; Cheng CH; Yu TM; Chuang YW; Huang ST
Transplant Proc; 2012 Apr; 44(3):676-9. PubMed ID: 22483466
[TBL] [Abstract][Full Text] [Related]
2. Serum adipokine levels in renal transplant recipients.
Shu KH; Wu MJ; Chen CH; Cheng CH; Yu TM; Chuang YW; Huang ST; Tsai SF; Lo YC; Weng SC; Wen MC; Ho HC
Transplant Proc; 2014; 46(2):381-4. PubMed ID: 24655968
[TBL] [Abstract][Full Text] [Related]
3. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
[TBL] [Abstract][Full Text] [Related]
4. Coronary artery calcification in kidney transplant recipients with long-term follow-up.
Shu KH; Tsai IC; Ho HC; Wu MJ; Chen CH; Cheng CH; Yu TM; Chuang YW; Huang ST
Transplant Proc; 2012 Apr; 44(3):687-90. PubMed ID: 22483469
[TBL] [Abstract][Full Text] [Related]
5. Hypoadiponectinemia correlates with metabolic syndrome in kidney transplantation patients.
Lee MC; Lee CJ; Chou KC; Shih MH; Hsu BG
Transplant Proc; 2011 Sep; 43(7):2601-5. PubMed ID: 21911131
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of the metabolic syndrome in kidney transplantation.
Kishikawa H; Nishimura K; Kato T; Kobayashi Y; Arichi N; Okuno A; Fujii N; Kyo M; Takahara S; Ichikawa Y
Transplant Proc; 2009; 41(1):181-3. PubMed ID: 19249509
[TBL] [Abstract][Full Text] [Related]
7. Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction.
Aso Y; Suganuma R; Wakabayashi S; Hara K; Nakano T; Suetsugu M; Matsumoto S; Nakamachi T; Takebayashi K; Morita K; Inukai T
Transl Res; 2009 Oct; 154(4):175-82. PubMed ID: 19766961
[TBL] [Abstract][Full Text] [Related]
8. Plasma adiponectin distribution in a Mediterranean population and its association with cardiovascular risk factors and metabolic syndrome.
Salas-Salvadó J; Granada M; Bulló M; Corominas A; Casas P; Foz M
Metabolism; 2007 Nov; 56(11):1486-92. PubMed ID: 17950098
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin as a biomarker of clinical manifestation of metabolic syndrome.
Tajtákova M; Petrásova D; Petrovicová J; Pytliak M; Semanová Z
Endocr Regul; 2006 Mar; 40(1):15-9. PubMed ID: 16964963
[TBL] [Abstract][Full Text] [Related]
10. Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease.
Hajer GR; van der Graaf Y; Olijhoek JK; Edlinger M; Visseren FL
Am Heart J; 2007 Oct; 154(4):750.e1-7. PubMed ID: 17893004
[TBL] [Abstract][Full Text] [Related]
11. Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects.
Kim BJ; Kim TY; Koh JM; Kim HK; Park JY; Lee KU; Shong YK; Kim WB
Clin Endocrinol (Oxf); 2009 Jan; 70(1):152-60. PubMed ID: 18494864
[TBL] [Abstract][Full Text] [Related]
12. Hyperleptinemia positively correlated with metabolic syndrome in renal transplant recipients.
Lee MC; Lee CJ; Ho GJ; Lee CC; Shih MH; Chou KC; Hsu BG
Clin Transplant; 2010; 24(4):E124-9. PubMed ID: 20236136
[TBL] [Abstract][Full Text] [Related]
13. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
[TBL] [Abstract][Full Text] [Related]
14. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR
Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic effects of rosiglitazone in nondiabetic patients with metabolic syndrome.
Aquilante CL; Kosmiski LA; Zineh I; Rome LC; Knutsen SD
Pharmacotherapy; 2010 Mar; 30(3):236-47. PubMed ID: 20180607
[TBL] [Abstract][Full Text] [Related]
16. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events.
Laryea M; Watt KD; Molinari M; Walsh MJ; McAlister VC; Marotta PJ; Nashan B; Peltekian KM
Liver Transpl; 2007 Aug; 13(8):1109-14. PubMed ID: 17663411
[TBL] [Abstract][Full Text] [Related]
18. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
19. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
Misra KB; Endemann SW; Ayer M
Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
